Hepatic Steatosis in Patients with Chronic Viral Hepatitis C Treated with Direct Acting Antivirals

Abstract Hepatic steatosis is a frequent pathological finding in patients with chronic viral C infection (HCV) and can be independently associated increased alcohol consumption, type 2 diabetes, obesity hyperlipidemia. All these factors lead to the development of hepatic HCV. There are several noninvasive techniques scores used for diagnosing quantifying liver steatosis. Successful eradication HCV interferon-free treatment regimens has been suggested improve level The precise mechanisms responsible beneficial effects currently under investigation, but it thought that decrease inflammation replication contribute resolution Moreover, overall enhancement health metabolic may also have significant impact.